Log In
BCIQ
Print this Print this
 

UCB7665

  Manage Alerts
Collapse Summary General Information
Company UCB Group
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat immunological diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today